FDA Inspection
Mission Pharmacal CompanyMission Pharmacal Company – FDA Inspection, Sep 22, 2022
Record Details
This FDA Inspection record concerns Mission Pharmacal Company, with an inspection on September 22, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Mission Pharmacal Company
- Inspection Date
- September 22, 2022
- Product Type
- Drugs
View Company Profile
ID · 8319387b-93ab-42e5-9d7e-44089969d14c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1180935
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mission Pharmacal Company
8| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2023 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| April 4, 2019 | VAI | Dallas District Office | New Drug Evaluation |
| September 20, 2018 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| May 4, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Mission Pharmacal Company
- FDA Inspection 1219105 - 2023-06-27
- FDA Inspection 1085124 - 2019-04-04
- FDA Inspection 1067651 - 2018-09-20
- FDA Inspection 1019109 - 2017-05-04
- FDA Inspection 866629 - 2014-02-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.